181 related articles for article (PubMed ID: 30134235)
1. Frequent Mutations in Natural Killer/T Cell Lymphoma.
Zhang Y; Li C; Xue W; Zhang M; Li Z
Cell Physiol Biochem; 2018; 49(1):1-16. PubMed ID: 30134235
[TBL] [Abstract][Full Text] [Related]
2. Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma.
Jiang L; Gu ZH; Yan ZX; Zhao X; Xie YY; Zhang ZG; Pan CM; Hu Y; Cai CP; Dong Y; Huang JY; Wang L; Shen Y; Meng G; Zhou JF; Hu JD; Wang JF; Liu YH; Yang LH; Zhang F; Wang JM; Wang Z; Peng ZG; Chen FY; Sun ZM; Ding H; Shi JM; Hou J; Yan JS; Shi JY; Xu L; Li Y; Lu J; Zheng Z; Xue W; Zhao WL; Chen Z; Chen SJ
Nat Genet; 2015 Sep; 47(9):1061-6. PubMed ID: 26192917
[TBL] [Abstract][Full Text] [Related]
3. Mutational Analysis of Extranodal NK/T-Cell Lymphoma Using Targeted Sequencing with a Comprehensive Cancer Panel.
Choi S; Go JH; Kim EK; Lee H; Lee WM; Cho CS; Han K
Genomics Inform; 2016 Sep; 14(3):78-84. PubMed ID: 27729836
[TBL] [Abstract][Full Text] [Related]
4. Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type.
Dobashi A; Tsuyama N; Asaka R; Togashi Y; Ueda K; Sakata S; Baba S; Sakamoto K; Hatake K; Takeuchi K
Genes Chromosomes Cancer; 2016 May; 55(5):460-71. PubMed ID: 26773734
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type.
Lee S; Park HY; Kang SY; Kim SJ; Hwang J; Lee S; Kwak SH; Park KS; Yoo HY; Kim WS; Kim JI; Ko YH
Oncotarget; 2015 Jul; 6(19):17764-76. PubMed ID: 25980440
[TBL] [Abstract][Full Text] [Related]
6. Mutational profile and EBV strains of extranodal NK/T-cell lymphoma, nasal type in Latin America.
Montes-Mojarro IA; Chen BJ; Ramirez-Ibarguen AF; Quezada-Fiallos CM; Pérez-Báez WB; Dueñas D; Casavilca-Zambrano S; Ortiz-Mayor M; Rojas-Bilbao E; García-Rivello H; Metrebian MF; Narbaitz M; Barrionuevo C; Lome-Maldonado C; Bonzheim I; Fend F; Steinhilber J; Quintanilla-Martinez L
Mod Pathol; 2020 May; 33(5):781-791. PubMed ID: 31822801
[TBL] [Abstract][Full Text] [Related]
7. Advances in multiple omics of natural-killer/T cell lymphoma.
Xiong J; Zhao WL
J Hematol Oncol; 2018 Dec; 11(1):134. PubMed ID: 30514323
[TBL] [Abstract][Full Text] [Related]
8. Activated janus kinase 3 expression not by activating mutations identified in natural killer/T-cell lymphoma.
Guo Y; Arakawa F; Miyoshi H; Niino D; Kawano R; Ohshima K
Pathol Int; 2014 Jun; 64(6):263-6. PubMed ID: 24965108
[TBL] [Abstract][Full Text] [Related]
9. Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma.
Koo GC; Tan SY; Tang T; Poon SL; Allen GE; Tan L; Chong SC; Ong WS; Tay K; Tao M; Quek R; Loong S; Yeoh KW; Yap SP; Lee KA; Lim LC; Tan D; Goh C; Cutcutache I; Yu W; Ng CC; Rajasegaran V; Heng HL; Gan A; Ong CK; Rozen S; Tan P; Teh BT; Lim ST
Cancer Discov; 2012 Jul; 2(7):591-7. PubMed ID: 22705984
[TBL] [Abstract][Full Text] [Related]
10. Full-spectral genome analysis of natural killer/T cell lymphoma highlights impacts of genome instability in driving its progression.
Chen Z; Huang H; Hong H; Huang H; Weng H; Yu L; Xiao J; Wang Z; Fang X; Yao Y; Yue JX; Lin T
Genome Med; 2024 Apr; 16(1):48. PubMed ID: 38566223
[TBL] [Abstract][Full Text] [Related]
11. Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.
Dufva O; Kankainen M; Kelkka T; Sekiguchi N; Awad SA; Eldfors S; Yadav B; Kuusanmäki H; Malani D; Andersson EI; Pietarinen P; Saikko L; Kovanen PE; Ojala T; Lee DA; Loughran TP; Nakazawa H; Suzumiya J; Suzuki R; Ko YH; Kim WS; Chuang SS; Aittokallio T; Chan WC; Ohshima K; Ishida F; Mustjoki S
Nat Commun; 2018 Apr; 9(1):1567. PubMed ID: 29674644
[TBL] [Abstract][Full Text] [Related]
12. Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sézary syndrome.
Kiel MJ; Sahasrabuddhe AA; Rolland DCM; Velusamy T; Chung F; Schaller M; Bailey NG; Betz BL; Miranda RN; Porcu P; Byrd JC; Medeiros LJ; Kunkel SL; Bahler DW; Lim MS; Elenitoba-Johnson KSJ
Nat Commun; 2015 Sep; 6():8470. PubMed ID: 26415585
[TBL] [Abstract][Full Text] [Related]
13. KMT2D and TP53 mutation status improve the prognostic value of the International Prognostic Index (IPI) stratification in ENKTL patients.
Gao Y; Li Y; Ma G; Zhao G; Liu H
Neoplasma; 2020 May; 67(3):636-643. PubMed ID: 32064880
[TBL] [Abstract][Full Text] [Related]
14. Targeting the JAK/STAT pathway in cytotoxic T lymphocytes (CTL) by Next Generation Sequencing (NGS).
Gigante M; Diella S; Ranieri E
Methods Mol Biol; 2014; 1186():253-68. PubMed ID: 25149312
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-negative extranodal "true" natural killer-cell lymphoma harbouring a KDM6A mutation.
Tsuyama N; Asaka R; Dobashi A; Baba S; Mishima Y; Ueda K; Oguchi M; Tsuji H; Hatake K; Takeuchi K
Hematol Oncol; 2018 Feb; 36(1):328-335. PubMed ID: 28695659
[TBL] [Abstract][Full Text] [Related]
16. What we should know about natural killer/T-cell lymphomas.
Xiong J; Zhao W
Hematol Oncol; 2019 Jun; 37 Suppl 1():75-81. PubMed ID: 31187536
[TBL] [Abstract][Full Text] [Related]
17. Alterations in ATR in nasal NK/T-cell lymphoma and chronic active Epstein-Barr virus infection.
Liu A; Takakuwa T; Luo WJ; Fujita S; Aozasa K
Cancer Sci; 2006 Jul; 97(7):605-10. PubMed ID: 16827800
[TBL] [Abstract][Full Text] [Related]
18. Molecular underpinning of extranodal NK/T-cell lymphoma.
Huang Y; de Leval L; Gaulard P
Best Pract Res Clin Haematol; 2013 Mar; 26(1):57-74. PubMed ID: 23768641
[TBL] [Abstract][Full Text] [Related]
19. The Pathologic and Genetic Characteristics of Extranodal NK/T-Cell Lymphoma.
Kim H; Ko YH
Life (Basel); 2022 Jan; 12(1):. PubMed ID: 35054466
[TBL] [Abstract][Full Text] [Related]
20. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]